Role of platelets and platelet receptors in cancer metastasis

Martin Schlesinger

doi:10.1186/s13045-018-0669-2

journal article Open Access Oct 11, 2018

Role of platelets and platelet receptors in cancer metastasis

Martin Schlesinger

Journal of Hematology & Oncology Vol. 11 No. 1 · Springer Science and Business Media LLC

View at Publisher Save 10.1186/s13045-018-0669-2

Topics

No keywords indexed for this article. Browse by subject →

References

205

[1]

Menter DG, Tucker SC, Kopetz S, Sood AK, Crissman JD, Honn KV. Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev. 2014;33:231–69. 10.1007/s10555-014-9498-0

[2]

Trousseau. Phlegmasia alba dolens. Clin Medicale L’Hotel-Dieu Paris. 2nd ed. Paris: JB Bailliere & Fils; 1865. p. 654–712.

[3]

Gasic GJ, Gasic TB, Galanti N, Johnson T, Murphy S. Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer. 1973;11:704–18. 10.1002/ijc.2910110322

[4]

Hilgard P. The role of blood platelets in experimental metastases. Br J Cancer. 1973;28:429–35. 10.1038/bjc.1973.168

[5]

Hilgard P, Heller H, Schmidt CG. The influence of platelet aggregation inhibitors on metastasis formation in mice (3LL). Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1976;86:243–50. 10.1007/bf00286943

[6]

Karpatkin S, Pearlstein E. Role of platelets in tumor cell metastases. Ann Intern Med. 1981;95:636–41. 10.7326/0003-4819-95-5-636

[7]

Contribution of platelets to tumour metastasis

Laurie J. Gay, Brunhilde Felding-Habermann

Nature Reviews Cancer 2011 10.1038/nrc3004

[8]

Contursi A, Sacco A, Grande R, Dovizio M, Patrignani P. Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting. Cell Mol Life Sci. 2017;74:3491–507. 10.1007/s00018-017-2536-7

[9]

Li N. Platelets in cancer metastasis: to help the “villain” to do evil. Int J Cancer. 2016;138:2078–87. 10.1002/ijc.29847

[10]

Wojtukiewicz MZ, Sierko E, Hempel D, Tucker SC, Honn KV. Platelets and cancer angiogenesis nexus. Cancer Metastasis Rev. 2017;36:249–62. 10.1007/s10555-017-9673-1

[11]

Weiss L. Metastatic inefficiency. Adv Cancer Res. 1990;54:159–211. 10.1016/s0065-230x(08)60811-8

[12]

Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol. 1998;153:865–73. 10.1016/s0002-9440(10)65628-3

[13]

Nieswandt B, Hafner M, Echtenacher B, Männel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 1999;59:1295–300.

[14]

Zucchella M, Dezza L, Pacchiarini L, Meloni F, Tacconi F, Bonomi E, et al. Human tumor cells cultured “in vitro” activate platelet function by producing ADP or thrombin. Haematologica. 1989;74:541–5.

[15]

Aitokallio-Tallberg A, Kärkkäinen J, Pantzar P, Wahlström T, Ylikorkala O. Prostacyclin and thromboxane in breast cancer: relationship between steroid receptor status and medroxyprogesterone acetate. Br J Cancer. 1985;51:671–4. 10.1038/bjc.1985.101

[16]

Aitokallio-Tallberg AM, Viinikka LU, Ylikorkala RO. Increased synthesis of prostacyclin and thromboxane in human ovarian malignancy. Cancer Res. 1988;48:2396–8.

[17]

Yu L-X, Yan L, Yang W, Wu F-Q, Ling Y, Chen S-Z, et al. Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein. Nat Commun. 2014;5:5256. 10.1038/ncomms6256

[18]

Ward Y, Lake R, Faraji F, Sperger J, Martin P, Gilliard C, et al. Platelets promote metastasis via binding tumor CD97 leading to bidirectional signaling that coordinates transendothelial migration. Cell Rep. 2018;23:808–22. 10.1016/j.celrep.2018.03.092

[19]

Han X, Guo B, Li Y, Zhu B. Tissue factor in tumor microenvironment: a systematic review. J Hematol Oncol. 2014;7:54. 10.1186/s13045-014-0054-8

[20]

Adams GN, Rosenfeldt L, Frederick M, Miller W, Waltz D, Kombrinck K, et al. Colon cancer growth and dissemination relies upon thrombin, stromal PAR-1, and fibrinogen. Cancer Res. 2015;75:4235–43. 10.1158/0008-5472.can-15-0964

[21]

Queiroz KCS, Shi K, Duitman J, Aberson HL, Wilmink JW, van Noesel CJM, et al. Protease-activated receptor-1 drives pancreatic cancer progression and chemoresistance. Int J Cancer. 2014;135:2294–304. 10.1002/ijc.28726

[22]

Tsopanoglou NE, Maragoudakis ME. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors. J Biol Chem. 1999;274:23969–76. 10.1074/jbc.274.34.23969

[23]

Chen D, Abrahams JM, Smith LM, McVey JH, Lechler RI, Dorling A. Regenerative repair after endoluminal injury in mice with specific antagonism of protease activated receptors on CD34+ vascular progenitors. Blood. 2008;111:4155–64. 10.1182/blood-2007-10-120295

[24]

Konstantoulaki M, Kouklis P, Malik AB. Protein kinase C modifications of VE-cadherin, p120, and beta-catenin contribute to endothelial barrier dysregulation induced by thrombin. Am J Physiol Lung Cell Mol Physiol. 2003;285:L434–42. 10.1152/ajplung.00075.2003

[25]

Shao B, Wahrenbrock MG, Yao L, David T, Coughlin SR, Xia L, et al. Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of trousseau syndrome. Blood. 2011;118:4015–23. 10.1182/blood-2011-07-368514

[26]

Oleksowicz L, Bhagwati N, DeLeon-Fernandez M. Deficient activity of von Willebrand’s factor-cleaving protease in patients with disseminated malignancies. Cancer Res. 1999;59:2244–50.

[27]

Dvorak HF, Quay SC, Orenstein NS, Dvorak AM, Hahn P, Bitzer AM, et al. Tumor shedding and coagulation. Science. 1981;212:923–4. 10.1126/science.7195067

[28]

Auwerda JJA, Yuana Y, Osanto S, de Maat MPM, Sonneveld P, Bertina RM, et al. Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma. Thromb Haemost. 2011;105:14–20. 10.1160/th10-03-0187

[29]

Alonso-Escolano D, Strongin AY, Chung AW, Deryugina EI, Radomski MW. Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins. Br J Pharmacol. 2004;141:241–52. 10.1038/sj.bjp.0705606

[30]

Melnikova VO, Mourad-Zeidan AA, Lev DC, Bar-Eli M. Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis. J Biol Chem. 2006;281:2911–22. 10.1074/jbc.m508683200

[31]

Chew EC, Wallace AC. Demonstration of fibrin in early stages of experimental metastases. Cancer Res. 1976;36:1904–9.

[32]

Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell–mediated elimination of tumor cells

Joseph S. Palumbo, Kathryn E. Talmage, Jessica V. Massari et al.

Blood 2005 10.1182/blood-2004-06-2272

[33]

Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, et al. Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. Blood. 2007;110:133–41. 10.1182/blood-2007-01-065995

[34]

Palumbo JS, Barney KA, Blevins EA, Shaw MA, Mishra A, Flick MJ, et al. Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function. J Thromb Haemost. 2008;6:812–9. 10.1111/j.1538-7836.2008.02938.x

[35]

Platelet-Derived Transforming Growth Factor-β Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor Reactivity

Hans-Georg Kopp, Theresa Placke, Helmut Rainer Salih

Cancer Research 2009 10.1158/0008-5472.can-09-2123

[36]

Placke T, Örgel M, Schaller M, Jung G, Rammensee H-G, Kopp H-G, et al. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells. Cancer Res. 2012;72:440–8. 10.1158/0008-5472.can-11-1872

[37]

Placke T, Salih HR, Kopp H-G. GITR ligand provided by thrombopoietic cells inhibits NK cell antitumor activity. J Immunol. 2012;189:154–60. 10.4049/jimmunol.1103194

[38]

Duffau P, Seneschal J, Nicco C, Richez C, Lazaro E, Douchet I, et al. Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci Transl Med. 2010;2:47ra63. 10.1126/scitranslmed.3001001

[39]

Haselmayer P, Grosse-Hovest L, von Landenberg P, Schild H, Radsak MP. TREM-1 ligand expression on platelets enhances neutrophil activation. Blood. 2007;110:1029–35. 10.1182/blood-2007-01-069195

[40]

Xiang B, Zhang G, Guo L, Li X-A, Morris AJ, Daugherty A, et al. Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway. Nat Commun. 2013;4:2657. 10.1038/ncomms3657

[41]

Platelet-Mediated Modulation of Adaptive Immunity

Bennett D Elzey, Jun Tian, Robert J Jensen et al.

Immunity 2003 10.1016/s1074-7613(03)00177-8

[42]

Platelets subvert T cell immunity against cancer via GARP-TGFβ axis

Saleh Rachidi, Alessandra Metelli, Brian Riesenberg et al.

Science Immunology 2017 10.1126/sciimmunol.aai7911

[43]

Metelli A, Salem M, Wallace CH, Wu BX, Li A, Li X, et al. Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer. J Hematol Oncol. 2018;11:24. 10.1186/s13045-018-0570-z

[44]

Haemmerle M, Taylor ML, Gutschner T, Pradeep S, Cho MS, Sheng J, et al. Platelets reduce anoikis and promote metastasis by activating YAP1 signaling. Nat Commun. 2017;8:310. 10.1038/s41467-017-00411-z

[45]

Xu XR, Carrim N, Neves MAD, McKeown T, Stratton TW, Coelho RMP, et al. Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies. Thromb J. 2016;14:29. 10.1186/s12959-016-0100-6

[46]

Saboor M, Ayub Q, Ilyas S. Moinuddin. Platelet receptors; an instrumental of platelet physiology. Pak J Med Sci. 2013;29:891–6. 10.12669/pjms.293.3497

[47]

Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8:1227–34. 10.1038/nm1102-1227

[48]

Crockett-Torabi E. Selectins and mechanisms of signal transduction. J Leukoc Biol. 1998;63:1–14. 10.1002/jlb.63.1.1

[49]

Kansas GS. Selectins and their ligands: current concepts and controversies. Blood. 1996;88:3259–87. 10.1182/blood.v88.9.3259.bloodjournal8893259

[50]

McEver RP. Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj J. 1997;14:585–91. 10.1023/a:1018584425879

Showing 50 of 205 references

Cited By

578

HOX genes and tumor metastasis: epigenetic regulatory mechanisms

Junwei Li, Jinhua Yan · 2026

Clinica Chimica Acta

The emerging roles of platelet-derived extracellular vesicles in disease

Can Lou, Xiaohong Cai · 2025

Annals of Medicine

Unlocking the potential: Receptor-mediated targeted drug delivery in cancer therapy

Balaji Palanisamy, Abul Kalam Azad Mandal · 2025

Pathology - Research and Practice

Collagen remodeling-mediated signaling pathways and their impact on tumor therapy

Zihang Yuan, Bo Lin · 2025

Journal of Biological Chemistry

Platelets and diseases: signal transduction and advances in targeted therapy

Yuchen Tian, Yao Zong · 2025

Signal Transduction and Targeted Th...

Decoding thrombosis through code: a review of computational models

Noelia Grande Gutiérrez, Debanjan Mukherjee · 2024

Journal of Thrombosis and Haemostas...

The Role of Anesthetic Management in Lung Cancer Recurrence and Metastasis: A Comprehensive Review

Jaewon Huh, Wonjung Hwang · 2024

Journal of Clinical Medicine

Anesthetic Approaches and Their Impact on Cancer Recurrence and Metastasis: A Comprehensive Review

Hoon Choi, Wonjung Hwang · 2024

Cancers

Prognostic relevance of platelet lymphocyte ratio (PLR) in gastric cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis

Shufu Hou, Dandan Song · 2024

Frontiers in Oncology

Association between CT-based adipose variables, preoperative blood biochemical indicators and pathological T stage of clear cell renal cell carcinoma

Zehua Sun, Yumei Zhang · 2024

Heliyon

The localization, origin, and impact of platelets in the tumor microenvironment are tumor type-dependent

Ophélie Le Chapelain, Soumaya Jadoui · 2024

Journal of Experimental & Clini...

New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies

Pratibha Pandey, Fahad Khan · 2023

Biomedicine & Pharmacotherapy

Anesthesia and cancer recurrence: an overview

Etrusca Brogi, Francesco Forfori · 2022

Journal of Anesthesia, Analgesia an...

Neutrophils, Cancer and Thrombosis: The New Bermuda Triangle in Cancer Research

Mélanie Langiu, Ana-Luisa Palacios-Acedo · 2022

International Journal of Molecular...

Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review

Sergiusz Łukasiewicz, Marcin Czeczelewski · 2021

Cancers

Anti-oncogenic activities exhibited by paracrine factors of MSCs can be mediated by modulation of KITLG and DKK1 genes in glioma SCs in vitro

Nazneen Aslam, Elham Abusharieh · 2021

Molecular Therapy - Oncolytics

Blockade of Platelets Using Tumor-Specific NO-Releasing Nanoparticles Prevents Tumor Metastasis and Reverses Tumor Immunosuppression

Yan Xu, Jiwei Liu · 2020

ACS Nano

EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis

Anthony Genna, Aline M. Vanwynsberghe · 2020

Cancers

The CCL5/CCR5 Axis in Cancer Progression

Donatella Aldinucci, Cinzia Borghese · 2020

Cancers

Metrics

578

Citations

205

References

Details

Published: Oct 11, 2018
Vol/Issue: 11(1)
License: View

Authors

M

Martin Schlesinger

Pharmaceutical Institute, Pharmaceutical and Cell Biological Chemistry, University of Bonn, 53121 Bonn, Germany

Cite This Article

Martin Schlesinger (2018). Role of platelets and platelet receptors in cancer metastasis. Journal of Hematology & Oncology, 11(1). https://doi.org/10.1186/s13045-018-0669-2

Role of platelets and platelet receptors in cancer metastasis

You May Also Like